image
Healthcare - Medical - Devices - NASDAQ - CR
$ 31.3
-3.1 %
$ 903 M
Market Cap
-10.43
P/E
CASH FLOW STATEMENT
-58.5 M OPERATING CASH FLOW
33.89%
-15.6 M INVESTING CASH FLOW
36.40%
126 M FINANCING CASH FLOW
46.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Establishment Labs Holdings Inc.
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -84.6 M
Depreciation & Amortization 7.58 M
Capital Expenditures -6.11 M
Stock-Based Compensation 14.4 M
Change in Working Capital 0
Others 6.28 M
Free Cash Flow -64.6 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (84.6) (78.5) (75.2) (41.1) (38.1) (38.1) (21.1) (34.9) (22.2)
Depreciation & Amortization 7.6 4.9 4.3 4.1 3.7 3.3 2.8 1.9 0.6
Deferred Income Tax (2.2) (3.7) 86 K 7 K 2.5 0.8 (13.9) 5.0 2.9
Stock Based Compensation 14.4 14.4 13.4 10.4 5.7 6.5 7.3 3.3 3.1
Other Operating Activities 6.3 8.6 26.8 5.5 1.4 2.2 5.0 7.1 3.1
Change in Working Capital 0 (34.1) (21.5) (6.4) 12.3 (4.6) (14.0) (14.3) (1.8)
Cash From Operations (58.5) (88.5) (52.2) (27.5) (12.5) (30.0) (33.9) (32.0) (14.3)
INVESTING CASH FLOW
Capital Expenditures (6.1) (24.5) (34.3) (6.7) (3.9) (7.0) (1.8) (0.9) (10.6)
Other Items (9.5) 0 (0.5) (0.4) (1.7) (0.8) (4.0) 96 K (0.2)
Cash From Investing Activities (15.6) (24.5) (34.8) (7.2) (5.6) (7.8) (5.7) (0.8) (10.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 4 K (0.4) 0 (0.2) 0 (4.5) (2.0)
Total Debt Repaid 24.5 0 96.4 (0.2) (0.3) 24.5 (0.3) 23.0 14.3
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 1.9 3.9 3.9 4.2 1.1 (1.5) 81.8 (3.3) 7.9
Cash From Financing Activities 125.9 86.2 100.3 4.1 64.7 22.8 81.5 43.0 20.2
CHANGE IN CASH
Net Change In Cash 50.3 (26.3) 12.9 (31.1) 46.9 (15.0) 41.8 10.4 (4.8)
FREE CASH FLOW
Free Cash Flow (64.6) (113.1) (86.4) (34.3) (16.4) (37.0) (35.7) (32.9) (24.8)